| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | C11 ELISA Kit; Cathepsin G like 1 ELISA Kit; Cathepsin G-like 1 ELISA Kit; CCPI ELISA Kit; CGL 1 ELISA Kit; CGL1 ELISA Kit; CSP B ELISA Kit; CSPB ELISA Kit; CTLA 1 ELISA Kit; CTLA-1 ELISA Kit; CTLA1 ELISA Kit; CTSGL1 ELISA Kit; Cytotoxic serine protease B ELISA Kit; Cytotoxic T lymphocyte associated serine esterase 1 ELISA Kit; Cytotoxic T lymphocyte proteinase 2 ELISA Kit; Cytotoxic T-lymphocyte proteinase 2 ELISA Kit; Fragmentin 2 ELISA Kit; Fragmentin-2 ELISA Kit; GRAB_HUMAN ELISA Kit; Granzyme 2 ELISA Kit; Granzyme B (granzyme 2; cytotoxic T lymphocyte associated serine esterase 1) ELISA Kit; Granzyme B ELISA Kit; Granzyme-2 ELISA Kit; GranzymeB ELISA Kit; GRB ELISA Kit; Gzmb ELISA Kit; Hlp ELISA Kit; Human lymphocyte protein ELISA Kit; Lymphocyte protease ELISA Kit; Protease; serine; B ELISA Kit; SECT ELISA Kit; T cell serine protease 1 3E ELISA Kit; T cell serine protease 1-3E ELISA Kit; T-cell serine protease 1-3E ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, cell culture supernates, tissue homogenates. |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
granzyme B (GZMB) is a biological molecule commonly studied in cell biology research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P10144
Biological context
Researchers often monitor granzyme B (GZMB) in serum, plasma, cell culture supernates, and tissue homogenates. to better understand themes such as signal transduction pathways, cell cycle control, and stress-response programs. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in granzyme B (GZMB) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, phosphorylation-dependent signaling nodes, stress markers, and organelle proteins) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, granzyme B (GZMB) may also appear under names such as C11 and Cathepsin G like 1. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that granzyme B (GZMB) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
A triple combination strategy for nasopharyngeal carcinoma: Aptamer-guided liposomal chemotherapy, engineered NK cells, and Fc-enhanced PD-L1 antibody therapy
C Yao, L Wang, W Liu, N Shi, Z Liao, Y Fu,Acta Pharmaceutica Sinica B,2025
Combined treatment with anti-PSMA antibody and human peripheral blood-derived NK cells for castration-resistant prostate cancer
F Wang, N Xing, J Li,Frontiers in Immunology,2025
HKDC1 promotes ovarian cancer progression through boosting lipid metabolism and immune escape by stabilizing G6PC/G6PC2
Y Wang, J Chen, Z Wang, X Luo, N Wu,Communications Biology,2025
Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma
W Yan, X Shi, Y Zhao, X Liu, X Jia, L Gao,Nature Communications,2025
Adipose stem cell exosomes, stimulated by pro-inflammatory factors, enhance immune evasion in triple-negative breast cancer by modulating the HDAC6/STAT3/PD-L1 pathway through the transporter UCHL1
Q Zhu, K Zhang, Y Cao, Y Hu,Cancer Cell International,2024
TLR9 activation induces immunosuppression and tumorigenesis via PARP1/PD-L1 signaling pathway in oral squamous cell carcinoma
L Ma,American journal of physiology. Cell physiology,2024
Astragaloside IV-PESV Repressed T Cell Immunosuppression by Inhibiting PD-L1 Expression in Prostate Cancer through STAT3 Pathway
X You,Journal of Food Biochemistry,2023
M2 macrophage exosomal LINC01001 promotes non-small cell lung cancer development by affecting METTL3 and glycolysis pathway
L Xu,Cancer gene therapy,2023
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
CL Yeh,Journal of experimental & clinical cancer research,2024
The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer
L Wang,Immunological Investigations,2022
1The interrupted effect of autophagic flux and lysosomal function induced by graphene oxide in p62-dependent apoptosis of F98 cells
C Zhang,J Nanobiotechnology,2020
Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells
Liang Wang, et al,Biomedicine & Pharmacotherapy,2019
Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell anti-tumor responses in vitro
/,Journal of Biological Chemistry,2012